|
|||||
|
|
| 青光眼药物治疗的回顾和展望 | |
| 引用本文： | 邱敬华,刘旭阳,武正清.青光眼药物治疗的回顾和展望[J].国际眼科杂志,2007,7(3):754-758. |
| 作者姓名： | 邱敬华 刘旭阳 武正清 |
| 作者单位： | 1. 421001,中国湖南省衡阳市,南华大学附二医院眼科 2. 610041,中国四川省成都市,四川大学华西医院眼科 3. 423000,中国湖南省郴州市,湘南学院附属-医院眼科 |
| 摘 要： | 青光眼在全世界范围内是一个主要的致盲眼病.高眼压是多数青光眼主要的危险,也是抗青光眼药物治疗的重点.随着人们对青光眼发病机制的研究以及药理学知识和技术的发展,抗青光眼药物也有了很大进展.现就目前正在使用的抗青光眼药物做一综述性回顾并介绍正在研究开发的抗青光眼新药的药效及降眼压机制. |
| 关 键 词： | 青光眼 眼压 药物治疗 抗青光眼药物 药物治疗 glaucoma management drug expectation 降眼压机制 新药 开发 使用 发展 知识和技术 药理学 研究 发病机制 重点 高眼压 致盲眼病 范围 世界 |
| 修稿时间： | 2007-05-092007-05-16 |
Retrospection and expectation on drug management of glaucoma |
|
| Jing-Hua Qiu,Xu-Yang Liu,Zheng-Qing Wu.Retrospection and expectation on drug management of glaucoma[J].International Journal of Ophthalmology,2007,7(3):754-758. | |
| Authors: | Jing-Hua Qiu Xu-Yang Liu Zheng-Qing Wu |
| Institution: | 1 Department of Ophthalmology, University of South China, 421001, Hunan Province, China;2 Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China;3 Department of Ophthalmology, the First Affiliated Hospital, Xiangnan Unviersity, 423000, Hunan Province, China |
| Abstract: | Glaucoma represents a major cause of vision loss throughout the world. Elevated intraocular pressure is a major risk factor and available anti-glaucoma drugs treat this facet of the disease. With the development of study in pathogenesy of glaucoma and pharmacology, it have made a great progress in anti-glaucoma drug. The aims of this article are to provide an overview of current drug management of glaucoma and introduce new drug being investigated about pharmaco-dynamic action and mechanism. |
| Keywords: | glaucoma intraocular pressure drug treatment |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ | |